The Swedish health care company has signed a distribution agreement for India and an exclusive agreement in the UK.
BioGaia has signed a non-exclusive agreement with Pharma Base SA for the rights to sell BioGaia’s ProTectis Baby Drops in India. Under the agreement, Pharma Base will cooperate with a local distributor for the marketing and sales of the drops, which will be sold under BioGaia’s own brand. The registration of the product will start 2014 and the launch is planned to the beginning of 2015. Marketing of the BioGaia drops will be focused on the Mumbai region and in the state of Maharashtra.
BioGaia has also extended its global contract with Nestle Nutrition by signing an agreement with the company’s UK infant nutrition business for the exclusive rights to sell BioGaia’s ProTectis Baby Drops in the United Kingdom and Ireland. Launch is planned to take place in the beginning of 2015.